Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eye Strain Relief PM is a **homeopathic sterile ophthalmic ointment** developed, manufactured, and distributed by TRP Company for temporary relief of symptoms associated with eye strain and ocular discomfort, including dry, red, tired, or irritated eyes, difficulty focusing or reading, double vision, headache, eye fatigue, and sleeplessness. The product contains a **fixed combination of micro-diluted homeopathic ingredients** including conium maculatum, euphrasia, natrium muriaticum, physostigma venenosum, ruta graveolens, senega officinalis, and valeriana officinalis in an ointment base containing lactose, lanolin alcohol, mineral oil, and white petrolatum. Its claimed activity is based on **traditional homeopathic practice rather than a defined pharmacologic mechanism**, and it does not have a validated conventional molecular target or evidence-based mechanism of action comparable to approved small molecules or biologics. The labeling indicates that its claims have not been reviewed by the Food and Drug Administration, and TRP Company's homeopathic ophthalmic products have been the subject of FDA warning activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eye Strain Relief PM.